Controlled trial of oral 5-aminosalicylic acid for the prevention of early relapse in Crohn's disease

Autor: FRANCHIS, R. DE, OMODEI, P., RANZI, T., BRIGNOLA, C., ROCCA, R., PRADA, A., PERA, A., VECCHI, M., PIANO, M. DEL, FERRARA, A., BELLOLI, C., PIODI, L., FRAMARIN, L., ASTEGIANO, M., RICCIOLI, F. A., MEUCCI, G.
Zdroj: Alimentary Pharmacology & Therapeutics; October 1997, Vol. 11 Issue: 5 p845-852, 8p
Abstrakt: Recent data indicate that 5-aminosalicylic acid (5-ASA) is most effective in preventing relapse of Crohn's disease in patients with a short duration of remission before enrolment.
Databáze: Supplemental Index